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The mechanisms underlying detachment of foetal membranes after birth in cows are still unclear. To address this problem in a systematic
manner, we performed the first holistic transcriptome study of bovine placentomes antepartum (AP; nZ4 cows) and intrapartum (IP;
nZ4 cows) using Affymetrix GeneChip Bovine Genome Arrays. Three placentomes were extracted from each cow, and tissue samples
from the contact zones of the placentomes (foeto-maternal units) were recovered by systematic random sampling and processed for RNA
extraction and for stereological quantification of cellular composition. Statistical analysis of microarray data (false discovery rate 1%)
revealed 759 mRNAs with at least twofold higher levels in the samples of the AP group, whereas 514 mRNAs showed higher levels in the
IP group. The differentially expressed genes were classified according to biological processes and molecular functions using the
Functional Annotation Clustering tool of the DAVID Bioinformatics Resources. Genes with higher mRNA levels in the AP group were
nearly completely related to mitotic cell cycle and tissue differentiation. During parturition, a complete shift occurred because the genes
with higher mRNA levels in IP were nearly all related to three different physiological processes/complexes: i) apoptosis, ii) degradation of
extra cellular matrix and iii) innate immune response, which play a fundamental role in placental detachment. These results are an
excellent basis for future studies investigating the molecular basis of retained foetal membranes.
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Anatomically, the bovine placenta is characterised
as synepitheliochorial placenta (Wooding et al. 1997).
It consists of 70–150 functional foeto-maternal units
(Björkman & Sollen 1960), the placentomes. Each
placentome is composed of a maternal caruncle and
a foetal cotyledon. With ongoing pregnancy, the
foetal villi invade intimately and extensively within the
deeper branching caruncular crypts (reviewed in
McNaughton & Murray (2009)).
Towards the end of pregnancy, placental maturation is
a prerequisite for the subpartal detachment and release
of foetal membranes. At the cellular level, the placental
maturation is characterised by typical changes of
the maternal crypt epithelium, which decreases in
height and number of cells. Additionally, contacts withq 2012 Society for Reproduction and Fertility
ISSN 1470–1626 (paper) 1741–7899 (online)foetal trophoblastic cells increase as well with the
underlying maternal connective tissue (Boos et al.
2003). Areas denuded of epithelial cells also appear
within the maternal epithelial lining of the crypts.
Placental maturation results in a reduction of the
distance between the foetal and maternal blood supplies
to meet the growing nutritional demands of the foetus
in the last months of pregnancy (Björkman 1954,
Björkman & Sollen 1960, Woicke et al. 1986, Williams
et al. 1987, Schoon 1989, Stallmach et al. 2001).
The initiation of parturition occurs as a result of
activation of the foetal hypothalamus–pituitary–adrenal
(HPA) axis. The reasons for its activation are still not
elucidated, but different theories are discussed: mat-
uration of the foetal hypothalamus; response of the foetal
hypothalamus to placental hormones; and foetalDOI: 10.1530/REP-11-0204
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86 D Streyl, H Zerbe, S Bauersachs and othersstressors due to hypoxia, hypocapnia, changes in blood
pressure or blood glucose (reviewed in Wood (1999)).
By activation of the HPA, the ACTH is released by the
pituitary. In parallel, the binding capacity of the plasma
for cortisol increases, which reduces the free cortisol
and this reduces the negative feedback effect of ACTH
to the pituitary. Additionally, the response of the foetal
adrenal glands increases with foetal age (Glickman &
Challis 1980). The increase in foetal cortisol concen-
tration induces the endometrial prostaglandin synthesis
by two different pathways (Whittle et al. 2000):
oestrogen dependent as well as oestrogen independent.
In the oestrogen-independent pathway, cortisol
enhances the expression of prostaglandin synthase
(PTGS2) within the foetal trophoblast cells of the
placenta. Therefore, prostaglandin E2 (PGE2) is released
in the placenta, which stimulates the conversion of
pregnenolone to C19 steroids, which are aromatised
by 17a-hydroxylase and aromatase to oestrogens. This
increase in oestrogen levels leads to the activation of
PTGS2 in the maternal endometrium, which increases
the production and release of PGF2a. The effects of
PGF2a are different. In the myometrium, it lowers the
threshold of the oxytocin receptor to respond to oxytocin
and increases by this the myometrial contractions
indirectly, but has also a direct effect on the myometrium
(reviewed by Taverne & Noakes (2009)). Another effect
of the increased PGF2a production, which has been
shown in cows and goats, is the induction of regression
of the corpus luteum. Therefore, prostaglandins are main
regulators of the initiation of parturition and are essential
for initiating smooth muscle contractions.
Oestrogen has also a direct effect on the myometrium
by increasing contraction-associated proteins (Olson
2003, Mendelson 2009), like connexins, which form
gap junctions to coordinate myometrial contractions.
Another essential effect of oestrogens is the softening of
the birth canal, namely the cervix, the vagina and the
associated tissues, by altering the structure of collagen
fibres (reviewed by Taverne & Noakes (2009)).
The separation of the placental components involves
a wide range of different processes. An increase in
the proportion of collagen in the cotyledons throughout
gestation in contrast to a decreased proportion in
the maternal part was demonstrated (Sharpe et al.
1989). During labour, contractions of the myometrium
result in pressure changes in the cotyledonary villi leading
to alternating hyperaemic and ischaemic conditions and
finally the physical separation of the foeto-maternal unit
(reviewed in McNaughton & Murray (2009)). Further-
more, the cotyledonary villi collapse when the umbilical
cord ruptures in parturition (Joosten & Hensen 1992),
resulting in a reduced surface area. At the cellular level,
this process is characterised by a number of morpho-
logical changes in the maternal crypt epithelium. Shortly
before parturition, the number of epithelial cells increases
in contrast to the number of giant trophoblast cells (GC)Reproduction (2012) 143 85–105that is reduced (Boos et al. 2003). It has also been
described that the expression of major histocompatibility
complex class II (MHC-II) in a subset of binucleate cells
(BNC) in the near term placentomes is beneficial for the
maturation process. These MHC-II antigens of the foetus
are presented to the dam, which modulates the maternal
immune system required for the placental separation
(reviewed in McNaughton & Murray (2009)). The roles of
single extracellular matrix-degrading enzymes, namely
matrix metallopeptidases 2 (MMP2) and 9 (MMP9),
as well as of the tissue inhibitor of metallopeptidase 2
(TIMP2) in placental maturation have been studied
during parturition. It has been shown by immunohistolo-
gical analysis as well as gene expression analysis that
these genes are associated with the process of expulsion
of the foetal membranes (Walter & Boos 2001, Boos
et al. 2003, Takagi et al. 2007). Further, an increase
in the number of apoptotic cells in maternal crypt
epithelium, maternal stroma and foetal chorionic epi-
thelium during pregnancy has been observed, suggesting
an important role of regulated cell death in normal
expulsion of the foetal membranes (Boos et al. 2003).
Retained foetal membranes (RFM) in cattle is defined as
the failure to expel foetal membranes within a physio-
logical time period of 8–12 h post partum (Sheldon 2004).
RFM can lead to life threatening conditions in mammals
including women. For dairy cows, there is an average
incidence of 3–12% in industrialised countries (Esslemont
& Kossaibati 1996, Sheldon 2004) also demonstrating
the economic importance of this complication.
So far, many studies of single genes at the mRNA
or protein level were performed that analysed only
single aspects of this complex process. To obtain a more
holistic view, a transcriptome analysis of well-defined
tissue samples before and intraparturition was performed
to identify changes in mRNA concentrations that
indicate molecular pathways involved in the regulation
of detachment of the foetal membranes. This improved
understanding can help to facilitate the development
of new strategies in the prevention and therapy of RFM.Results
Morphometrical analysis
To ensure the comparability of the tissue samples with
regard to cellular composition, the volume fraction of
the epithelial cells of each sample was determined by
morphometrical analysis. Whereas the variation in the
volume fraction of epithelial cells between individual
tissue samples was relatively high (Vv 0.02–0.47
epithelial cells), the variation between animals (mean
volume fraction of epithelial cells of all nine tissue
samples per animal Vv 0.15–0.35) was clearly reduced
due to the pooling of samples per animal. There was no



































































































Figure 1 (A) Scheme of systematic random sampling. Cross sections of a placentome covered by a grid (1!1 cm) are shown; grey: epithelial
tissue of the caruncle; light grey: caruncle stroma; red: epithelial tissue of the cotyledon. Ovals indicate the crosses of the grid lying on the zone
of foeto-maternal contact. Filled ovals indicate the locations of tissue sampling (adapted, with permission, from Fig. 8.9 in Rüsse I & Sinowatz F
1991 Lehrbuch der Embryologie der Haustiere. Berlin: Paul Parey Verlag). (B) Mean volume density (Vv(Epithelial cells/Placentome) of the epithelial cells.
The S.D. is marked by a bar. In the upper diagram, three placentomes of one animal (three IP) were shown. Three placentomes were sampled per
animal. In the middle diagram, the mean volume density of each placentome per animal was shown. In the lowest diagram, the mean volume density
of epithelial cells is shown for all the eight animals.
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To identify peripartal transcriptome changes in the foeto-
maternal unit, samples recovered 12 days before the
estimated day of calving (antepartum (AP), nZ4) and
samples taken immediately after delivery of the calf
(intrapartum (IP), nZ4) were analysed using Affymetrix
GenChip Bovine Genome Arrays. In total, eight
Affymetrix microarrays were hybridised and evaluated.
A heatmap of the pair-wise distances of the single data
sets showed high correlation between the animals of
the individual experimental groups (data not shown).
Statistical analysis (SAM, two-class unpaired (Tusher
et al. 2001)) revealed 1650 probe sets with significant
differences (false discovery rate 1%, Rtwofold) in their
hybridisation signals between the placentomes of the
AP group vs the IP group. These probe sets correspondedTable 1 Results of quantitative real-time RT-PCR.
Mean CT S.D.
Gene IP AP IP A
B2M 19.1 19.9 0.4 0.
CD14 a 28.5 30.7 0.8 1.
CXCL2 25.5 27.8 0.5 0.
FGF2 31.6 33.6 1.0 0.
GPX3 22.1 23.3 0.5 0.
HPGD a 26.3 27.3 1.2 0.
MT2A 23.9 25.7 1.0 0.
PTX3 31.9 34.0 0.6 1.
SDS a 27.4 28.9 0.9 0.
KLF5 26.3 25.0 0.6 0.
LBP 34.6 33.0 1.1 0.
TRIB3 24.3 21.4 0.8 0.
FC, fold change.
aRoche master mix, all others with ABI master mix.
www.reproduction-online.orgto 1226 different genes, 743 with higher transcript levels
APand 483 with higher levels IP (Supplementary Table 2,
see section on supplementary data given at the end of
this article). Twelve selected genes were verified by
quantitative real-time RT-PCR (Table 1). The correspond-
ing primer sets are shown in Supplementary Table 1,
see section on supplementary data given at the end of
this article.
The differentially expressed genes were analysed
with the Functional Annotation Clustering tool of the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) Bioinformatics Resources. The result
of this integrated analysis of different functional
databases (e.g. GO, KEGG pathways, SP-PIR keywords,
etc.) are clusters of quantitatively enriched functional
terms with overlapping sets of genes with a significant
cluster enrichment score (geometric mean in log scaleqPCR Array
P FC IP/AP P value FC IP/AP P value
7 1.9 0.037 1.3 0.004
6 5.8 0.014 2.8 !0.001
7 4.4 0.001 4.5 !0.001
8 3.3 0.021 2.3 !0.001
7 2.6 0.002 2.4 !0.001
5 2.4 0.051 2.4 0.005
6 3.8 0.005 2.4 !0.001
2 3.4 0.021 2.7 !0.001
5 3.5 0.010 3.1 !0.001
8 K2.9 0.014 K2.1 !0.001
9 K3.7 0.036 K2.1 !0.001
4 K8.6 0.001 K5.1 !0.001
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Table 2 Results of functional annotation clustering of genes up-regulated 12 days antepartum.
Functional annotation cluster descriptiona
Enrichm.
scoreb Genesc
Cell cycle (63, 4.2), mitotic cell cycle (54, 4.6), cell division (45, 6.2), M phase of mitotic cell cycle (45, 5.3),
mitosis (38, 8.2)
19.15 91
Cell cycle (63, 4.2), regulation of cell cycle (41, 2.1) 12.72 90
Chromosome (35, 2.4), chromosome pericentric region (19, 6.9), centromere (14, 11.4) 6.65 35
Chromosome organisation and biogenesis (24, 1.7), chromosome segregation (14, 6.0), mitotic sister chromatic
segregation (10, 8.8)
4.98 25
Microtubule cytoskeleton (37, 2.4), cytoskeleton (71, 1.6), intracellular non-membrane-bound organelle (107, 1.4) 4.48 107
Cytoskeleton organisation and biogenesis (39, 2.0), microtubule cytoskeleton organisation and biogenesis (12, 3.9),
spindle organisation and biogenesis (7, 9.5)
3.75 37
Substrate-specific transmembrane transporter (43, 1.3), symporter activity (19, 3.3), solute: sodium symporter
activity (11, 6.0), carboxylic acid transmembrane activity (9, 3.4), organic acid: sodium symporter activity (7, 7.9)
2.88 46
Enzyme regulator activity (48, 1.6), regulation of signal transduction (38, 1.8), GTPase regulator activity (29, 2.0),
small GTPase regulator activity (22, 2.4), Ras protein signal transduction (20, 2.1), Rho protein signal
transduction (12, 2.8), Ras guanyl nucleotide exchange factor activity (11, 3.4), Rho guanyl-nucleotide exchange
factor activity (10, 3.6)
2.40 82
Cytoskeletal part (49, 1.8), microtubule (20, 2.3), microtubule-based process (19, 2.3), cytoskeleton-dependent
intracellular transport (10, 2.1)
2.01 54
Purine nucleotide binding (89, 1.3), nucleotide binding (75, 1.4), ATP-binding (63, 1.5), nucleotide phosphatase-
binding region: ATP (53, 1.8), kinase activity (53, 1.5), protein amino acid phosphorylation (36, 1.4)
1.97 190
Cellular lipid metabolic process (33, 1.4), steroid metabolic process (15, 2.2), lipid synthesis (9, 2.9), steroid
biosynthesis (7, 5.4)
1.87 39
Development process (152, 1.3), cell differentiation (87, 1.3), cell development (65, 1.4), apoptosis (43, 1.5),
programmed cell death (43, 1.5), regulation of apoptosis (27, 1.4), negative regulation of apoptosis (17, 2.0)
1.83 152
Endosome (18, 2.4); endosome membrane (8, 2.4) 1.81 18
Oxidoreductase (33, 1.6), iron ion binding (18, 1.6) 1.58 45
Calmodulin binding (10, 2.1), IQ calmodulin-binding region (8, 2.7) 1.39 11
Cytoskeleton protein binding (26, 1.7), actin cytoskeleton (18, 1.8), actin binding (16, 1.5) 1.35 33
aBased on the most meaningful terms. bGeometric mean (in Klog10 scale) of member’s P values of the corresponding annotation cluster.
cTotal
number of different genes in a functional annotation cluster; in brackets: number of genes and fold enrichment of the functional term.
88 D Streyl, H Zerbe, S Bauersachs and othersof member’s Fisher Exact P values in a corresponding
annotation cluster). Before parturition, most significant
clusters were related to cell cycle and cell division,
transmembrane transporters and regulation of signal
transduction (Table 1). In parturition, the highest
enrichment scores were obtained for clusters related to
immune response, extracellular proteins, regulation of
apoptosis and different categories involved in tissue
remodelling (Table 2). The results of the text mining of
Medline abstracts (CoPub analysis) overall confirmed the
results of the DAVID analysis. For the genes with higher
mRNA levels in the AP placentome samples, almost
all overrepresented keywords were related to cell cycle
(46 genes) and the different phases of mitosis, including
DNA replication (24 genes) and its regulation (six genes;
Supplementary Table 3, see section on supplementary
data given at the end of this article). The analysis of the IP
up-regulated genes showed overrepresented keywords
related to innate immune response (20 genes), mem-
brane degradation (11 genes), inhibition of matrix
metallopeptidases (MMPs; five genes) and angiogenesis
(13 genes; Supplementary Table 4, see section on
supplementary data given at the end of this article).
Using Pathway Architect software, interaction net-
works were built for genes up-regulated during
parturition. DAVID clusters with similar functional
terms were further integrated resulting in three large
functional groups: immune response (clusters 1, 2, 5, 10,Reproduction (2012) 143 85–10511, 14, 22, 25), combination of different clusters related
to tissue remodelling (clusters 4, 6, 8, 9, 13, 17, 27) and
apoptosis (cluster 7). Each of these functional groups was
analysed by CoPub and the overrepresented genes were
used in the interaction networks. Networks were drawn
based on different types of interactions like binding,
regulation, expression, transport, assignment to a protein
family or a biological process. Proteins were assigned to
their primary cellular localisation. Figure 2 shows the
interaction network for the genes involved in immune
response (31 genes assigned). The network of genes
involved in apoptosis (15 genes assigned) is shown in
Fig. 3. Figure 4 shows the network of genes related to
tissue remodelling (37 genes assigned; Tables 3–6).Localisation of selected proteins
To examine the expression pattern and the localisation
of PTGS2, MMP14, TIMP1 nuclear factor of kappa
light polypeptide gene enhancer in B-cells inhibitor,
alpha (NFKBIA), BCL2/adenovirus E1B 19 kDa interact-
ing protein 3 (BNIP3) and X-linked inhibitor of apoptosis
(XIAP), we have carried out immunohistochemical
investigations using paraffin sections from formalin-
fixed bovine placentomes, which were taken AP or
during birth (IP; Fig. 5 and Table 7).
Staining intensity for the antibody against PTGS2






























































Proteins (       differentially expressed;        added) 
Interaction types:       binding;      expression;      regulation;      promoter binding;
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Figure 2 Interaction network of genes with higher mRNA levels in intrapartum related to immune response processes. Proteins (orange if differentially
expressed and white with a pink outline if added) are assigned to their primary cellular localisations. Interaction types: dark blue squares: binding;
light blue squares: expression; green squares: regulation; green circles: promoter binding; orange circles: protein modification; purple circles:
member; green triangle: transport; cyan diamond: metabolism; yellow ovals: biological process.
Expression profiling of bovine placentomes 89uninucleated trophoblast cells (UNC) during the AP
period, whereas in samples from IP placentomes the
cytoplasmic expression of PTGS2 was increased and
could be estimated as strong. No distinct immunostain-
ing for PTGS2 could be observed in GC at both time
points. The caruncular epithelial cells covering the basal
plate and the septa displayed a weak to moderate
cytoplasmic expression for PTGS2. No PTGS2 staining
was found in stromal cells of the uterus AP and IP. IP,www.reproduction-online.orga few PTGS2-positive mesenchymal cells, could be
detected in the foetal stroma.
In IP samples, MMP14 was mostly expressed in
the UNC and GC. The immunostaining varied from
distinct to strongly positive. In the epithelium and the
stroma of the caruncular epithelium, a weak to moderate
immunostaining for MMP14 could be detected. The
mesenchymal cells of the chorionic plate and the primary

























































Proteins (       differentially expressed;        added)
Interaction types:       binding;      expression;      regulation;      promoter binding;
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Figure 3 Interaction network of genes with highest mRNA levels intrapartum according to DAVID clusters associated with cell death. Proteins
(orange if differentially expressed and white with a pink line, if added) are assigned to their primary cellular localisations. Interaction types: dark blue
squares: binding; light blue squares: expression; green squares: regulation; green circles: promoter binding; orange circles: protein modification;
purple circles: member; green triangle: transport; cyan diamond: metabolism; yellow ovals: biological process; red hexagons: functional biological
group/family.
90 D Streyl, H Zerbe, S Bauersachs and othersagainst MMP14. In AP samples, no difference for the
staining intensity for MMP14 in the caruncular epithe-
lium was observed. UNC expressed MMP14 moderately,
whereas the GC generally showed no or only weak
expression of MMP14. The endotheliums of the foetal
or maternal blood vessels were usually distinct positive
for MMP14. The foetal stroma cells of all villi displayed
a weak positive reaction for MMP14. In contrast, the
maternal stromal cells were negative.
TIMP1 immunostaining in the UNC appeared weak
to moderate positive in AP samples, whereas the GC
expressed TIMP1 with a moderate to distinct intensity.
In IP, the staining intensity increased and could be
considered as distinct to strong positive in both cell
types. In the foetal stroma, the staining intensity was
stronger in AP. The caruncular epithelial cells showed a
moderate staining in IP, but somewhat attenuated
immunostaining for TIMP1 was seen in the specimen
obtained from AP. The maternal stromal cells showedReproduction (2012) 143 85–105a negative to weak expression before birth, which further
increased to moderate expression in the IP samples.
NFKBIA was localised in the UNC and GC in both AP
and IP bovine placentomes, but the staining intensity
of the UNC appeared more distinct in IP samples. The
maternal and foetal stroma showed a weak or moderate
staining at both time points. The expression in the
caruncular epithelium was weak to distinct positive and
no differences between the AP and IP samples could
be detected. Interestingly, during the antepartal phase,
the endothelium of the blood vessels was immuno-
positive for NFKBIA, but appeared negative during IP.
BNIP3 was expressed only weakly in some scattered
UNC and GC in IP samples. No immunostaining was
observed in UNC and GC in AP samples. Caruncular
epithelium and foetal stroma showed no BNIP3
immunostaining at both stages, whereas the staining
intensity appeared as increased in uterine stromal cells of
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Figure 4 Interaction network of genes with higher mRNA levels in intrapartum related to extracellular matrix remodelling. Proteins (orange if
differentially expressed and white with a pink outline if added) are assigned to their primary cellular localisations. Interaction types: dark
blue squares: binding; light blue squares: expression; light green squares: regulation; green circles: promoter binding; orange circles: protein
modification; purple circles: member; green triangle: transport; cyan diamond: metabolism; yellow ovals: biological process; blue hexagons:
functional biological group.
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Table 3 Results of functional annotation clustering of genes up-regulated intrapartum.
Functional annotation cluster descriptiona
Enrichm.
scoreb Genesc
Response to stress (64, 2.2), response to external stimulus (54, 3.1), defence response (43, 2.7), response to
wounding (40, 3.4), response inflammatory (28, 3.4)
9.15 86
Response to stimulus (135, 1.6), immune system process (75, 2.3), immune response
(60, 2.3), defence response (43, 2.7)
9.13 144
Membrane (172, 1.3), glycoprotein (170, 1.7), signal (157, 2.1), transmembrane (144, 1.3), signal peptide (138, 1.7),
secreted (91, 2.5), extracellular region (79, 2.2)
8.35 267
Extracellular region (79, 2.2), extracellular matrix (28, 3.0), proteinaceous extracellular matrix (27, 2.9) 7.68 80
Multi-organism process (28, 3.2), response to biotic stimulus (25, 2.9), response to virus (15, 5.5) 5.34 35
Development process (134, 1.5), cell differentiation (85, 1.7), cellular development process (85, 1.7), cell death (47,
2.1), apoptosis (44, 2.0), regulation of programmed cell death (31, 2.1), positive regulation of apoptosis (19, 2.7)
4.09 146
Organ morphogenesis (25, 2.2), vascular development (18, 3.4), anatomical structure formation (17, 3.3),
angiogenesis (16, 4.1)
4.00 34
Hydrolase activity (88, 1.4), protease (29, 2.4), zymogene (18, 3.6), metalloendopeptidase activity (14, 4.6) 3.96 95
Response to chemical stimulus (46, 2.8), behaviour (25, 2.8), cytokine–cytokine receptor interaction (19, 1.7),
chemotaxis (17, 4.2), G-protein-coupled receptor binding (10, 4.9), chemokine activity (7, 5.3)
3.66 63
Carbohydrate binding (22, 2.6), pattern binding (13, 4.2), polysaccharide binding (12, 4.2), glycosaminoglycan
binding (11, 4.0)
3.31 23
Carboxylic acid metabolic process (35, 2.2), organic acid metabolic process (35, 2.2), cellular lipid metabolic
process (35, 2.0), monocarboxylic acid metabolic process (22, 3.3), amine metabolic process (21, 1.7), fatty
acid metabolic process (17, 3.5)
3.26 63
Enzyme inhibitor activity (17, 2.3), endopeptidase inhibitor activity (14, 3.2), protease inhibitor activity (14, 3.2),
serine-type endopeptidase inhibitor activity (9, 3.1)
2.63 34
Regulation of development process (16, 2.2), hemopoietic or lymphoid development (15, 2.7), immune system
development (15, 2.5), regulation of cell differentiation (13, 3.0), myeloid cell differentiation (11, 4.4)
2.62 23
EGF-like region (22, 2.7), EGF-like, type 3 (16, 2.9), EGF-like calcium binding (9, 3.3), aspartic acid and asparagines
hydroxylation site (9, 3.2)
2.44 42
Regulation of body fluid levels (12, 3.6), wound healing (10, 2.8), blood coagulation (9, 3.3), haemostasis (9, 3.1) 2.36 13
Membrane organisation and biogenesis (18, 2.2), membrane invagination (15, 2.8), endocytosis (15, 2.8) 2.30 25
Cell communication (144, 1.3), signal transduction (131, 1.3), intracellular signalling cascade (59, 1.4), cell surface
receptor-linked signal transduction (59, 1.1)
2.30 144
Membrane fraction (37, 1.9), endoplasmic reticulum (20, 1.4), vesicular fraction (13, 2.7), microsome (12, 2.6) 2.21 46
Immune effector process (11, 3.5), adaptive immune response (8, 3.6), lymphocyte-mediated immunity (7, 3.4) 2.16 12
Reproduction (21, 1.4), reproductive process (18, 2.1), reproductive process in a multicellular organism (8, 4.0) 2.05 21
Signal transducer activity (87, 1.3), receptor activity (64, 1.2), transmembrane protein (39, 2.4) 2.05 134
Leukocyte activation (13, 2.3), lymphocyte activation (12, 2.4), T-cell activation (8, 2.5) 1.74 14
Chemical homeostasis (17, 2.3), cellular ion homeostasis (13, 2.2), metal ion homeostasis (9, 2.5), cytosolic
Ca ion homeostasis (7, 3.7)
1.66 21
Cellular structure morphogenesis (23, 1.7), cell morphogenesis (23, 1.7), cell growth (11, 2.1), regulation of
cell growth (9, 2.1)
1.46 26
Regulation of molecular function (25, 1.6), regulation of catalytic activity (23, 1.7), regulation of protein kinase
activity (13, 2.1), positive regulation of protein catalytic activity (13, 2.0)
1.39 33
aBased on the most meaningful terms. bGeometric mean (in Klog10 scale) of member’s P values of the corresponding annotation cluster.
cTotal
number of different genes in a functional annotation cluster; in brackets: number of genes and fold enrichment of the functional term.
92 D Streyl, H Zerbe, S Bauersachs and othersUNC and GC displayed a distinct to strong immunos-
taining for XIAP in IP samples, which appeared weaker in
AP samples. At both time points, the expression for XIAP
was weak in the caruncular epithelium and moderate
positive in foetal stromal cells. Maternal stromal cells
were always negative for XIAP.
There were no staining reactions in all used negative
controls (Supplementary Figure 1, see section on
supplementary data given at the end of this article).Discussion
The detailed molecular correlates of the process of
release of foetal membranes and the early steps of uterine
involution are unknown. Therefore, we performed the
first holistic transcriptome analysis of foeto-maternalReproduction (2012) 143 85–105units recovered from a defined animal model AP and IP.
This study facilitated a global detection of differential
gene expression and the identification of potentially
involved molecular pathways.Animal model and tissue sampling
In this study, bovine placentome samples collected
before the expected date of delivery (group AP) and
samples taken from IP-extracted placentomes (group IP)
were compared. Samples of group AP were collected
12–15 days before estimated term after undisturbed
gestation with an active Cl (P4O2 ng/ml) because a
decrease in P4 induces a significant shift in steroid
secretion (Takagi et al. 2002) and decreases epithelial
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Figure 5 Localisation of expression of selected proteins in antepartum (AP) and intrapartum (IP) placentomes: (A) immunostaining for PTGS2 in AP
placentomes: the staining intensity for PTGS2 of the uninucleated trophoblast cells (UNC) was moderate to distinct positive (thin arrows). In contrast,
all giant trophoblast cells (GC) were negative (bold arrows). fs, foetal stroma; ms, maternal stroma; sbZ50 mm; (B) immunostaining for PTGS2 in IP
placentomes: strong staining for the antibody against PTGS2 is restricted to the UNC (thin arrows), whereas the TGC are negative (bold arrows).
The cytoplasm of caruncular epithelium cells showed a weak to moderate expression for PTGS2 (arrowhead); sbZ50 mm; (C) immunostaining for
MMP14 in AP placentomes: TGC were only weak positive stained or negative (bold arrows), whereas the UNC (thin arrows) expressed MMP14
moderately; sbZ100 mm; (D) immunostaining for MMP14 in IP placentomes: strong immunostaining signals were detected in the UNC (thin
arrows), whereas the TGC exhibit a distinct staining intensity (bold arrows). A distinct to strong expression for MMP14 was localised in the fs cells.
sbZ50 mm; (E) immunostaining for TIMP1 in AP placentomes: TIMP1 was detected in the UNC (thin arrow) and the TGC (bold arrows) with a weak
to distinct staining pattern; sbZ50 mm; (F) immunostaining for TIMP1 in IP placentomes: the immunostaining for TIMP1 increased in the UNC
(thin arrows) and the TGC (bold arrows) to strong positive; sbZ50 mm; (G) immunostaining for NFKBIA in AP placentomes: UNC demonstrated
a distinct expression for NFKBIA (thin arrows). In contrast, TGC expressed NFKBIA strong (bold arrows); sbZ100 mm; (H) immunostaining for
NFKBIA in IP placentomes: the immunostaining appeared strong in the UNC (thin arrows) and moderate to distinct in the TGC (bold arrows);
sbZ50 mm; (I) immunostaining for BNIP3 in AP placentomes: no positive signals for BNIP3 were observed in the UNC and TGC; sbZ150 mm;
(J) immunostaining for BNIP3 in IP placentomes: some UNC (thin arrows) and TGC (bold arrow) demonstrated a weak expression for BNIP3, whereas
the staining intensity increased in the uterine stromal cells during birth; sbZ50 mm; (K) immunostaining for XIAP in AP placentomes: the UNC
(thin arrows) and TGC (bold arrow) showed weak to moderate XIAP expression; sbZ100 mm; (L) immunostaining for XIAP in placentomes of
intrapartal cattle: the staining intensity for XIAP was distinct to strong in the UNC (thin arrow) and the TGC (bold arrows). The fs were stained
moderate to distinct positive. sbZ50 mm.
96 D Streyl, H Zerbe, S Bauersachs and otherscompared to placentome samples extracted in labour
immediately after the end of the expulsion phase of
parturition (maximum of 15 min). The sampling was
done after expulsion of the calf to avoid interference
with the expulsion process and induction of RFM.
We strictly defined the experimental model to minimise
influences that alter physiological parturition including
the stage of placental expulsion, like prolonged partur-
ition, hypocalcaemia or low oestrogen levels (Schuler
et al. 2002, McNaughton & Murray 2009). Therefore,
gestations as well as the parturition were controlled
over the whole period.
During sampling, the foetal part of the placenta
was not separated from the maternal part to facilitate
detection of transcriptome changes of the whole
placental unit. Additionally, contaminations from the
counterpart cannot be excluded when placentomes are
manually separated. To ensure a similar tissue compos-
ition in all samples, systematic random sampling wasReproduction (2012) 143 85–105performed and nine samples from three placentomes
were pooled. Estimation of the volume fraction of
epithelial cells revealed large variations between
individual placentome samples that would lead to
much higher variation between animals due to tissue
sampling if only a single sample per animal was
analysed. As described previously (Mayhew 2008), the
sampling method is essential to avoid any bias in
generating gene expression data because differences of
the tissue composition or localisation of the tissue
sampling directly influence the results of gene
expression analyses (Wyatt et al. 2005).Overrepresented functional terms for the genes with
higher mRNA levels in AP placentome samples
Analysis of the mRNAs with higher levels in placentome
samples of the AP group revealed strongest over-
representation of functional categories related to cellwww.reproduction-online.org
Table 7 Results of immunohistochemistry analyses (Fig. 5).
Antibody UNC GC FS CE MS BV
PTGS2
Antepartal C/CC K K KC/C K C
Intrapartal CC/CCC K K/KC KC/C K C
MMP14
Antepartal C/CC K/KC KC C K CC
Intrapartal CC/CCC CC CC/CCC KC/C KC/C CC
TIMP1
Antepartal KC/C C/CC C/CC KC/C K/C C
Intrapartal CC CC/CCC KC/C C/CC KC/C C/CC
NFKBIA
Antepartal CC CC/CCC KC/C KC/CC KC CC
Intrapartal CCC C/CC KC/C KC/CC KC K
BNIP3
Antepartal K K K K C K
Intrapartal KC KC K K CC/CCC K
XIAP
Antepartal KC/C KC/C C KC K C/CC
Intrapartal CC/CCC CC/CCC C/CC KC K C/CC
UNC, uninucleated trophoblast cells; GC, giant trophoblast cells; CE, caruncular epithelium; FS, foetal stroma; MS, maternal stroma; BV, blood
vessels (K negative, KC weak, C moderate, CC distinct, CCC strong).
Expression profiling of bovine placentomes 97cycle and cell division (e.g. cell cycle, cell division,
mitosis, microtubule cytoskeleton, chromosome, etc.).
This observation is in line with histochemical studies
showing a decrease in (maternal) epithelial proliferation
near parturition (Boos et al. 2003). Cellular prolif-
eration and cell death are inversely proportional
during gestation and near parturition, where apoptosis
increases and proliferation declines (Boos et al. 2003).
The functional term ‘regulation of apoptosis’ was also
found in the DAVID analysis, whereas genes with higher
mRNA levels in AP were predominantly related to
negative regulation of cell death and those with higher
levels in IP with positive regulation of cell death. Genes
involved in the regulation of apoptosis are discussed in
detail. In addition, a large number of genes coding for
different transmembrane transporters (e.g. for glucose,
amino acids, fatty acids, sodium iodide, potassium/
chloride, zinc, vitamins, neurotransmitters, etc.) were
identified. Also a number of genes typically associated
with the establishment and maintenance of pregnancy
showed higher mRNA levels in the AP samples, e.g.
members of the pregnancy-associated glycoprotein
family (Pag3, PAG5, PAG6, PAG7, LOC100336184,
PAG9, PAG15, PAG17, PAG18 and PAG21) and
members of the family of prolactin-related proteins
(PRL, PRP-VII, PRP2 and PRP3). Expression of PAGs
and PRPs has been described in BNC and a role in
placenta formation and differentiation has been postu-
lated (Gootwine 2004, Hashizume 2007, Haig 2008).
Down-regulation of these genes might be a result of
decreasing number of BNC. The decline in number
of BNC shortly before parturition is typical in cases of
physiological release of the foetal membranes (Gross
et al. 2001).www.reproduction-online.orgOverrepresented functional terms for the genes with
higher mRNA levels in IP placentome samples
Genes related to immune response
Regulation of different pro-inflammatory cytokines is
essential for uterus activation and normal parturition
(Christiaens et al. 2008). Especially, in the last stage of
parturition, pro-inflammatory reactions are essential for
proper release of the foetal membranes and for a healthy
puerperal stage (Kelly 1996). At the level of mRNA, we
found elevated concentrations in the IP placentome
samples for mRNAs coding for CD14 molecule (2.8-fold
higher), CD36 molecule (thrombospondin receptor;
threefold higher), chemokine (C-X-C motif) ligand 2
(CXCL2; 4.9-fold higher), CXCL14 (2.1-fold higher),
chemokine (C-C motif) receptor 4 (CCR4; 2.1-fold),
macrophage expressed 1 (MPEG1; 2.5-fold) and macro-
phage scavenger receptor 1 (MSR1; 2.5-fold).
Up-regulation of these genes indicates increased
numbers of monocytes and/or macrophages (MPEG1
and MSR1) in the IP samples compared with AP
placentomes since specific expression in monocytes/
macrophages (e.g. CD14) or in macrophages (CXCL14)
has been shown (Oliveira & Hansen 2009). Also for
MPEG1 and MSR1, macrophage-specific expression has
been shown (Spilsbury et al. 1995 PMID: 7888681,
Freeman 1990 PMID: 1978939). A functional role of
bovine placental macrophages during parturition for the
release of foetal membranes has been suggested by
Miyoshi et al. (2002). Oliveira & Hansen (2009)
demonstrated that CD14(C) and CD68(C) macro-
phages are located in the maternal crypts but not in the
foetal part of the placentome. CD14 is an important
binding protein for lipopolysaccharides of Escherichia
coli, the typical pathogen in the post partum uterusReproduction (2012) 143 85–105
98 D Streyl, H Zerbe, S Bauersachs and others(Sheldon et al. 2008). In addition to its role in innate
immune responses to bacterial and other microbial
structures, CD14 also functions as a receptor involved in
the recognition and phagocytosis of cells undergoing
apoptosis (Gregory 2000). Thus, the role of endometrial
macrophages could be on one side clearing of apoptotic
cells and pathogen defence after parturition.
Nuclear factor kappa B (NFKB) is a key transcription
factor that regulates transcription of, e.g. different
cytokine genes involved in inflammatory reactions,
such as TNFA, IL1 and also expression of PTGS2
(Baeuerle & Baichwal 1997). The activity of NFKB is
regulated by several specific inhibitors such as NFKB
inhibitor alpha (NFKBIA), which prevents translocation
of NFKB to the nucleus (Baeuerle 1998). In the presented
study, a 2.4-fold higher expression of NFKBIA was
observed in IP placentomes. On protein level, staining
intensity in UNC was higher in IP samples. Interestingly,
distinct staining was found in or around caruncular
blood vessels of AP samples but not in IP placentomes.
This result could indicate a differential regulation of
leukocyte infiltration of the placentomes, via NFKB
regulation.
Macrophages have been shown to be the major
producers of pro-inflammatory cytokines like interleukin
1 beta (IL1B) and tumour necrosis factor alpha (TNFA) as
well as the chemokine IL8, which were described as
essential regulatory mediators during labour (Elliott et al.
1998, Goldenberg et al. 2000). For IL8, higher mRNA
levels (5.9-fold higher) were found in IP placentomes.
IL8 is one of the major mediators of the inflammatory
response and has been shown both to attract and to
activate PMNs (Colditz et al. 1989), the most prominent
postpartal uterine immune cells. It has been demon-
strated that IL8 can be produced by many cell types, e.g.
macrophages, endothelial cells and even phagocytising
PMNs (Bazzoni et al. 1991). IL8 expression is down-
regulated during gestation by high progesterone (P4)
concentrations (Barclay et al. 1993, Kelly et al. 1994). In
human placenta, IL8 production is increased after
spontaneous labour and was localised in the perivas-
cular area of foetal vessels in third-trimester placenta
(Elliott et al. 1998). The increase in IL8 mRNA levels
corresponds to the influx of PMNs and other immune
cells like macrophages that has been found immediately
before parturition (Yellon et al. 2003) and its known
synergism with the effects of PGE2 in attracting PMNs to
skin sites (Foster et al. 1989, Colditz 1990) suggests a
possible role for IL8 in initiation and progression of
labour through activation of PMNs, which release
proteolytic enzymes, such as collagenases and elastases
that degrade ECM contributing together with apoptosis
to foetal membrane rupture (Osmers et al. 1992, Winkler
& Rath 1996, Moore et al. 2006).
In the context of prostaglandin metabolism, two
mRNAs coding for prostaglandin synthases, namely
hydroxyprostaglandin dehydrogenase 15-(NAD;Reproduction (2012) 143 85–105HPGD) and PTGS2 (alias COX2), were identified as
up-regulated in the IP placentome samples (HPGD: 2.4-
fold, PTGS2: 2.4-fold). PTGS2 protein was mainly
detectable in the uninuclear trophoblast cells but also
to a lesser extent in the caruncular epithelium and blood
vessels. This is in line with investigations of the PTGS2
expression around parturition (Whittle et al. 2000) and
its essential role in the production of prostaglandins
PGF2a and PGE2, which are involved in the regulation of
every step of parturition: membrane rupture, cervical
dilatation, myometrial contractility, placental separation
and uterine involution (Olson et al. 1995). Myometrial
contractions at parturition are a product of uterine
activation and increased levels of genes involved in this
process, including PTGS2 and HPGD (Olson 2003,
Mendelson 2009), also described as uterine activation
proteins (UAPs). An additional indication for the
activation of the innate immune system was found by
up-regulation of many typical interferon-induced genes
(e.g. interferon-induced protein 44 like (IFI44; 4.8-fold
higher) and interferon induced with helicase C domain 1
(IFIH1; 2.7-fold higher)) and of members of the
complement system (e.g. complement component 1, r
subcomponent (C1R; 2.2-fold higher) and complement
component 7 (C7; 3.6-fold higher).
Remodelling of the extracellular matrix and regulation
of angiogenesis
DAVID analysis also revealed enrichment of genes
coding for proteins involved in ECM remodelling for
the mRNAs with higher levels in IP placentome samples.
The main groups of these genes were i) matrix
metallopeptidases: MMP1, MMP3, MMP9, MMP13,
MMP14 and MMP16; ii) TIMP metallopeptidase
inhibitors: TIMP1, TIMP3 and TIMP4 and iii) ADAM
metallopeptidases: ADAM9, ADAM19, ADAMDEC1,
ADAMTS4, ADAMTS5 and ADAMTSL4. The up-regula-
tion of MMP2 and MMP9 protein in relation to onset of
labour has been described in various species (Ulug et al.
2001, Walter & Boos 2001, Goldman & Shalev 2003,
Takagi et al. 2007). Especially, the up-regulation of
MMP9 protein, partially released by PMNs in the foetal
membranes (Osmers et al. 1995) with beginning
contractions (Tsatas et al. 1999, Goldman & Shalev
2003), is linked to the rupture of the foetal membranes
implicating an important role in placental separation.
MMP9 degrades type IV and V collagens and has been
shown to be present in tertiary granules of neutrophils
and MMP9 release can be induced by IL8 via activation
of chemokine (C-X-C motif) receptor 2 (CXCR2;
Chakrabarti & Patel 2005). Additionally, the expression
of MMP9 is regulated by a PTGS2–PGE2–EP4 receptor
axis in macrophages. Macrophages are able to secrete
active MMP9 after exposure to MMP1 or MMP3; both
of them are up-regulated in the IP group (2.8- and
2.7-fold respectively). These exposures also triggeredwww.reproduction-online.org
Expression profiling of bovine placentomes 99a quick release of TNFA, which could be blocked by
inhibitors of MMP1 and MMP3 (Steenport et al. 2009).
Pro-MMP9 is also activated by MMP3 and indirectly by
MMP14 (on protein levels also detected, see Fig. 5 and
Table 7), which activates MMP13 that also cleaves pro-
MMP9 (Pap et al. 2000, Elnemr et al. 2003, Dreier et al.
2004). The localisation and the increase in MMP14
protein in IP samples (foetal stroma, UNC) is in line with
recent findings and gives additional hints about the
importance of MMP14 in the process of foetal membrane
release (Dilly et al. 2011).
Furthermore, plasminogen activator, urokinase
(PLAU), whose mRNA is also up-regulated (2.5-fold) in
IP samples, is known to play a major role in degradation
of ECM (Tsatas et al. 1999). The function of PLAU is
to convert plasminogen to plasmin, which subsequently
activates MMPs, such as MMP3 and MMP9. PLAU is
also able to directly activate MMP9 (Zhao et al. 2008).
The simultaneous up-regulation of PLAU receptor
(PLAUR, 2.4-fold) mRNA and serpin peptidase inhibitor,
clade E (nexin, plasminogen activator inhibitor type 1),
member 1 (SERPINE1, 4.2-fold) mRNA indicates tight
regulation of ECM degradation in the placentomes
immediately after expulsion of the calf. Interestingly,
prostaglandins PGE2 and PGF2a are also able to increase
the expression of MMPs, especially MMP2 and MMP9,
and therefore the production of prostaglandins by
PTGS2 (also up-regulated in IP samples) could play a
role in the separation and release of the placenta
(Weinreb et al. 1997, Yoshida et al. 2002). MMP16
(2.2-fold up-regulated) is an activator of pro-MMP2 and
it could be demonstrated that the activation of pro-
MMP2 is enhanced by TIMP3 (2.2-fold) and by TIMP2
(Zhao et al. 2004). A disintegrin and metallopeptidases
(ADAMs) and ADAMs with thrombospondin motifs
(ADAMTS) are membrane-bound peptidases closely
related to MMPs. These multifaceted molecules bear
metallopeptidase and disintegrin domains endowing
them with features of both peptidases and adhesion
molecules. Peptidases of the ADAM family are associ-
ated with various physiological and pathological pro-
cesses like trophoblast invasion and matrix degradation
during pregnancy, angiogenesis and inflammation,
neurodegeneration and fibrosis, through shedding of
the apoptosis-inducing FAS ligand (van Goor et al.
2009). It was shown that catalytically active ADAM9
(2.3-fold), together with ADAM15 and ADAM17, is
associated with CD68C monocytes derived cells in
inflammatory tissues (Oksala et al. 2009). Since MMPs
and ADAMs are very potent collagenases, they have to
be tightly regulated to avoid uncontrolled tissue damage.
Three mRNAs for inhibitors of different MMPs, TIMP1,
TIMP3 (both 2.2-fold) and TIMP4 (2.1-fold) were also
identified as up-regulated in the IP placentome samples.
TIMP1 is the direct inhibitor of MMP1 (Vallon et al.
1997). Strongest expression of TIMP1 protein was
detected in GC (TGC) but also in all other areas of thewww.reproduction-online.orgplacentomes. Except for foetal stroma, staining intensity
was always higher in IP samples, which correlates with
up-regulation of TIMP1 mRNA in IP samples. The broad
expression could indicate a regulatory function in fine-
tuning the activity of MMPs such as MMP1, MMP2 and
MMP3. It has been shown for TIMP3 that expression is
strictly balanced with expression of MMP9 during early
gestation in the mouse (Teesalu et al. 1999). The process
of parturition is also associated with the regulation of
vascular remodelling-related genes like SERPINE1,
FBLN5, thrombospondin 1 (THBS1; 2.6-fold; Haddad
et al. 2008), angiopoietin 2 (ANGPT2; 4.4-fold) and
angiopoietin-like 4 (ANGPTL4; 2.7-fold). This process of
remodelling is also represented by the differential
regulation of different genes all described to be involved
in the process of angiogenesis and regulation of
angiogenesis (e.g. fibroblast growth factor 2 (basic;
FGF2; 2.3-fold), platelet/endothelial cell adhesion
molecule (PECAM1; 2.3-fold), vascular endothelial
growth factor A (VEGFA; K2.7-fold) and vasohibin 2
(VASH2; K2.4-fold)). Interestingly, VEGFA mRNA has
lower levels in IP samples, which could be a mechanism
to reduce vascular permeability (Zachary 1998, Farmer
et al. 2002). Since many genes involved in the biological
processes of ECM remodelling were also described in the
context of angiogenesis, the regulation of vascular
remodelling could also play a role in the release of
foetal membranes.
Apoptosis-related genes
DAVID analysis showed enrichment for apoptosis-
related genes for both the IP up-regulated and the IP
down-regulated genes. The majority of the genes with
lower levels in the IP placentome samples are known or
assumed to have negative effects on apoptosis whereas
the genes with increased mRNA levels are predom-
inantly positive regulators of programmed cell death.
Apoptosis has been shown to be an essential process
during the release of the foetal membranes and mat-
uration of the placenta before parturition (Boos et al.
2003, Keelan et al. 2003). The observed up-regulation of
typical monocyte/macrophage markers in IP placen-
tomes could also be associated with increased apoptosis
in the placentomes, since macrophages play an import-
ant role in clearance of apoptotic cells (Erwig & Henson
2007). In addition to pro-apoptotic signals, the reduction
of the blood supply to the placenta after umbilical
cord rupture could be a possible reason for induction
of apoptosis (Runic et al. 1998, McLaren et al. 1999).
One important gene family involved in the regulation of
apoptosis is the TNF receptor family (Baker & Reddy
1998). For two members of this gene family, namely
TNF receptor superfamily, member 1B (TNFRSF1B;
twofold) and TNF receptor superfamily, member 6b,
decoy (TNFRSF6B; 4.2-fold) higher mRNA levels were
found in IP placentomes. Furthermore, a number ofReproduction (2012) 143 85–105
100 D Streyl, H Zerbe, S Bauersachs and othersgenes associated with the TNF signalling pathway were
down-regulated in IP placentome samples, such as TNF
receptor-associated factors 3 and 6 (TRAF3, TRAF6;
K3.3-fold, K2.1-fold), Fas (TNFRSF6)-associated via
death domain (FADD; K2.6-fold) and Fas-associated
factor family member 2 (FAF2; K3.3-fold). Some of the
mRNAs with higher levels in the IP group compared
with the AP group are growth arrest and DNA damage-
inducible, beta (GADD45B), BNIP3; DnaJ (Hsp40)
homologue, subfamily A, member 3 (DNAJA3), eukary-
otic translation initiation factor 2-alpha kinase 2
(EIF2AK2; Table 7 and Supplementary Figure 1, see
section on supplementary data given at the end of this
article for the corresponding protein detections).
Increased expression of BNIP3 protein in UNC, GC
and uterine stromal cells during birth could indicate
increased apoptosis since BNIP3 a pro-apoptotic factor
of the Bcl-2 family was localised in IP maternal stroma.
The presence of this protein was also shown in human
placenta (Stepan et al. 2004). The expression of it is
associated with hypoxic situation, e.g. in necrotic
regions of malignant tumours (Sowter et al. 2001).
Genes with lower levels in IP samples that are
associated with cell survival and anti-apoptotic functions
are, e.g. CASP8 and FADD-like apoptosis regulator
(CFLAR; K3.8-fold), cell death-inducing DFFA-like
effector A (CIDEA; K4.8-fold) and XIAP (K3-fold;
Table 7 and Supplementary Figure 1, see section on
supplementary data given at the end of this article for the
corresponding protein detections). In contrast to the
findings of gene expression, expression of XIAP protein,
a known inhibitor of apoptosis (Straszewski-Chavez et al.
2004), was higher in IP samples. However, mRNA











































Reproduction (2012) 143 85–105expression profile between these time points is not
known, and the half-life of mRNA and protein is
different. Interestingly, XIAP was found in all different
parts of the placentome (UNC, GC, CE and BV) except
for the maternal stroma, where BNIP3 expression was
found. This indicates complex spatial regulation of
apoptosis in the placentome during birth.
This study is the first systematic analysis of
differential gene expression of bovine placentome
samples collected from contact zones before partur-
ition compared with the time immediately after
expulsion of the calf. Figure 6 summarises the findings
of this study to illustrate the complex processes in the
placentome during birth. The identified transcriptome
changes and protein localisations revealed a complex
regulation and interaction of immune system-related
processes, vascular, tissue and ECM remodelling, and
apoptosis. Particularly, the identified immune-related
genes suggest an important role of inflammatory cells,
such as macrophages and neutrophils, in the process of
release of foetal membranes. Furthermore, the results
of this study provide a basis for investigations of the
pathophysiology of disturbed release of foetal
membranes.Materials and Methods
Animal model
Each experimental group (AP and IP) consisted of four cows
(Bos taurus; Simmental breed), with two primiparous and
two polyparous in the second or third pregnancy. None of
the polyparous animals suffered from RFM in earlier calvings.
All pregnancies were monitored by regular clinical exam-







Figure 6 Scheme demonstrating the findings of this
microarray study. The foetal maternal contact zone is
shown exemplarily. In the boxes (light grey) biological
processes, to which genes in the IP group are associated
with: apoptosis, ECM remodelling, vascular remodelling
and immune response. The locations of the proteins
according to the results of immunohistochemistry
(Table 7). Proteins with stronger appearance IP (in bold)
and AP (in italic). Light blue: extracellular matrix; orange:
uninucleated trophoblast cells; rose: cotyledonary villous,
including foetal stroma; red: blood vessels; green: giant
trophoblast cells; white: caruncular epithelium; light grey:
caruncular stroma.
www.reproduction-online.org
Expression profiling of bovine placentomes 101exclude predisposing factors of dystocia or RFM, such as
subclinical hypocalcaemia or ketosis. Plasma P4 levels were
determined (Prakash et al. 1987), which were stable throughout
the last 3 weeks of gestation (O2 ng/ml). Animals of the AP
group underwent caesarean section 272G3 days after artifi-
cial insemination (AI). The animals of the IP group calved
288G7 days after AI. In all IP animals, parturition occurred
physiologically without any problems and the foetal mem-
branes were delivered in !6 h after calving.
All experiments with animals were conducted with per-
mission from the local veterinary authorities and in accordance
with the accepted standards of humane animal care.Tissue sampling
After rupture of the umbilical cord, three placentomes per
animal were collected. In the AP group, the placentomes were
collected under visual control. In the IP group, the placentomes
were recovered transvaginally by using an effeminator by
Reisinger (Heuwieser et al. 1985) within 15 min after rupture
of the umbilical cord. The tissue sampling was done system-
atically (Herbach et al. 2005; Fig. 1) as follows: the placen-
tomes were analysed as a foeto-maternal unit, therefore
maternal and foetal parts were not separated. Every placen-
tome was cut perpendicular to the luminal surface in
0.5 cm-thick slices, which were placed with the right cut
surface facing downwards on a sterile RNase-free surface. The
slices were covered with a grid (1!1 cm) and every point
hitting the visual foeto-maternal connection was counted.
These connecting points were divided by three resulting in
nZx, and a random number between 1 and x was determined,
where tissue samples were collected. Tissue cuboids
(w0.6!0.6!1.0 cm) were cut out and divided into three
parts of w0.2!0.2!0.3 cm. The middle part was transferred
into RNAlater (Ambion, Huntingdon, Cambridgeshire, UK),
incubated overnight at 4 8C and then stored at K20 8C until
further processing. The other samples were fixed in formalin
(3.7%) and paraformaldehyde (4.2%), respectively, and
routinely processed and embedded in paraffin.Morphometric analysis
Sections were stained with haematoxylin and eosin (H&E) and
evaluated using unbiased model-independent stereological
methods as described (Herbach et al. 2005). Morphometric
evaluation was carried out on a Videoplan image analysis
system (Zeiss-Kontron, Eching, Germany) attached to a
microscope by a colour video camera. Images were displayed
on a colour monitor at a 850! final magnification, and the
profiles of placentomes, epithelial cells and non-epithelial cells
were measured planimetrically by circling their contours with
a cursor on the digitising tablet of the image analysis system.
The volume density of epithelial cells in the placentomes
(Vv(Epithelial cells/Placentome)) was calculated by dividing the sum
of cross-sectional areas of epithelial cells by the sum of cross-
sectional areas of the placentome, the volume density of other
cells (Vv(Non-epithelial cells/Placentome)) was calculated analogue
to the Vv(Epithelial cells/Placentome). The morphometric data werewww.reproduction-online.organalysed by a Kruskal–Wallis test (SPSS 15.0; IBM Corporation,
Armonk, NY, USA).Microarray hybridisation and data analysis
Total RNA was isolated from the tissue samples of the
placentomes using Trizol Reagent (Invitrogen GmbH) accord-
ing to the manufacturer’s instructions. Tissue samples (nZ3) of
individual placentomes (nZ3) were pooled before isolation of
the RNA. Quantity and quality of total RNA were determined
by spectrometry and agarose gel electrophoresis. For every
animal, equal amounts of total RNA of the single placentomes
(nZ3) were pooled for microarray analysis. Preparation of
hybridisation probes for Affymetrix GeneChip Bovine Genome
Arrays (Affymetrix, Santa Clara, CA, USA) started from 10 mg
total RNA and was done using the One-Cycle Target
Labelling and Control Reagent package (Affymetrix). For the
hybridisation, wash and staining processes, the GeneChip
Hybridization, Wash and Stain Kit (Affymetrix) was used.
All steps were done according to the manufacturer’s protocol.
The processed arrays were scanned with a GeneChip Scanner
3000 7G with AutoLoader (Affymetrix).
Affymetrix CEL files were processed using log scale robust
multi-array analysis (RMA; Irizarry et al. 2003). Quality control
was done using different BioConductor tools, such as pseudo
images (BioC package AffyPLM), RNA degradation plots (BioC
package Affy), box plots, distance matrices and heatmaps.
After RMA processing probe sets were filtered based on
expression calls. Only such probe sets were used that had
present calls in at least three of four samples in at least one of
the experimental groups. Significance analysis was performed
using the ‘significance analysis of microarrays method’
(SAM, two-class unpaired; Tusher et al. 2001). If a transcript
was represented on the array by more than one probe set, the
mean signal ratio was calculated.
Identification of quantitatively enriched functional categories
was done using the ‘Functional annotation clustering’ tool
of the DAVID (Dennis et al. 2003). The text-mining tool CoPub
(Frijters et al. 2008) was used to identify biological keywords
associated with the differentially expressed genes. These
analyses were all based on the Entrez Gene ID of the putative
human orthologous genes. Interaction networks were built for
genes of selected functional groups using Pathway Architect
software (version 3.0.1, Stratagene, Heidelberg, Germany).
Most of the interactions and cellular localisations provided
by the Pathway Architect databases were checked. Additional
interactions found in the literature were assigned to the network.Quantitative real-time RT-PCR
The same RNA samples as for microarray analysis were used for
quantitative real-time RT-PCR (qPCR). First-strand cDNA was
synthesised starting from 1 mg total RNA with the Sprint RT
Complete-Double PrePrimed (6!8 well) kit (Takara Bio
Europe/Clontech, Saint-Germain-en-Laye, France). qPCR was
performed on a StepOne Real-Time PCR System, 48-well
(Applied Biosystems, Langen, Germany) by the use of the
Power SYBR Green PCR Master Mix (Applied Biosystems) or
the FastStart Universal SYBR Green Master (Rox; Roche) inReproduction (2012) 143 85–105













PTGS2 1:400, 20 h, 6 8C Polyclonal Anti-goat IgG rabbit 1:400, 30 min, rt Abcam plc Dako Deutschland
GmbH
MMP14 1:50, 20 h, 6 8C Monoclonal Anti-mouse IgG rabbit 1:300, 30 min, rt
TIMP1 1:100, 20 h, 5 8C Polyclonal Anti-rabbit IgG swine, 1:300, 30 min, rt
NFKBIA 1:100, 20 h, 5 8C Polyclonal Anti-rabbit IgG swine, 1:300, 30 min, rt
BNIP3 1:400, 20 h, 6 8C Monoclonal Anti-mouse IgG rabbit 1:300, 30 min, rt
XIAP 1:100, 20 h, 5 8C Polyclonal Anti-rabbit IgG swine, 1:300, 30 min, rt Abnova GmbH
c/o EMBLEM
rt, room temperature.
102 D Streyl, H Zerbe, S Bauersachs and othersa final volume of 20 ml. Primer sequences are shown in
Supplementary Table 1, see section on supplementary data
given at the end of this article. Annealing temperature was
60 8C for all PCRs. As control for DNA contamination, RNA
without RT was used as PCR template (KRT control). The cycle
number (CT) required to achieve a definite SYBR Green
fluorescence signal (CT threshold) was calculated (StepOne
Software v2.1, Applied Biosystems). The CT is correlated
inversely with the logarithm of the initial template concen-
tration. The CT determined for the target genes was normalised
against the housekeeping genes RPS23 and PPP2R5B (DCT;
Livak & Schmittgen 2001). Relative expression difference
between the IP and the AP samples was calculated from the
difference of the mean CT values (DDCT). All PCR fragments
were analysed on a DNA1000 Labchip (Agilent Technologies,
Waldbronn, Germany) to check amplification of a single
product and sequenced to verify the obtained PCR product.Immunohistochemistry
For immunohistochemical studies, 5 mm serial sections of each
placentome sample were collected on slides (SupraFrost Ultra
Plus, Menzel-Gläser; Gerhard Menzel Glasbearbeitungswerk
GmbH & Co KG, Braunschweig, Germany), which were
coated with aminopropyltriethoxysilane. Sections were pre-
incubated with proteinase XXIV 0.1% (Sigma, P8038) for
15 min and washed with PBS buffer pH 7.4. Endogenous
peroxidase activity was blocked with 0.1% H2O2 at room
temperature for 10 min.
Antigen localisation was achieved using the avidin–
biotin complex technique (ABC-technique; Hsu et al. 1981)
according to the following protocol. Paraffin sections (5 mm)
were dewaxed and subjected to the following immunohisto-
chemical staining schedule: i) elimination of endogenous
peroxidase activity with 0.5% H2O2 in PBS for 15 min at
20 8C; ii) elimination of non-specific protein binding by
incubation at 20 8C with 10% normal goat serum for 1 h;
iii) incubation overnight at 4 8C with one of the followingTable 9 Non-specific antibodies for isotype controls for immuno-
histochemistry.




Reproduction (2012) 143 85–105primary antibodies (Table 7) against PTGS2, MMP14, TIMP 1,
NFKBIA, BNIP3 and XIAP; iv) incubation with a corresponding
secondary biotin-conjugated antibody (Table 8); v) incubation
with HRP-conjugated ABC for 1 h at 20 8C and vi) treatment
with 0.05 mg/ml diaminobenzidine in PBS. Sections were
left unstained or counterstained in Mayer’s haematoxylin,
dehydrated and mounted with DePeX Eukitt (Riedel de Haen,
Seelze, Germany).
Protein Block Serum-Free solution (Dako, X0909, Hamburg,
Germany) was used to inhibit non-specific staining of primary
and secondary antibodies during the immunohistochemical
detection of antigens. As negative control, buffer (Dako) was
used instead of the specific primary antibody. As positive
controls, tissues were used, which is known to show specific
immunostaining with the antibodies used in this study. For
further negative control experiments, non-specific antibodies
(Table 9) diluted to the same final protein concentration like the
used specific antibodies were substituted for the primary
antibodies.
The used non-specific antibodies were matched to the host
species and isotype of the specific antibodies.Supplementary data
This is linked to the online version of the paper at http://dx.doi.
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